Harmonizome 3.0

UFM1-specific peptidase 1 (non-functional)

This gene encodes a protein that is similar to other Ufm1-specific proteases. Studies in mouse determined that Ufsp1 releases Ufm1 (ubiquitin-fold modifier 1) from its bound conjugated complexes which also makes it into an active form. Because the human UFSP1 protein is shorter on the N-terminus and lacks a conserved Cys active site, it is predicted to be non-functional.[provided by RefSeq, Nov 2009]

immunoglobulin heavy variable 1-38-4 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 6-7 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy diversity 3/OR15-3B (non-functional)

immunoglobulin heavy diversity 3/OR15-3A (non-functional)

thymopoietin pseudogene 2 (functional)

T cell receptor beta variable 23/OR9-2 (non-functional)

immunoglobulin lambda variable 5-48 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 3-35 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 3-38 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 7-1 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

ATP-binding cassette, sub-family C, member 6 pseudogene 1 (functional)

immunoglobulin kappa variable 3-7 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 25 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

adenosine deaminase, RNA-specific, B2 (non-functional)

This gene encodes a member of the double-stranded RNA adenosine deaminase family of RNA-editing enzymes and may play a regulatory role in RNA editing. [provided by RefSeq, Jul 2008]

immunoglobulin heavy variable 3/OR16-13 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin kappa variable 2D-24 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor gamma variable 10 (non-functional)

Predicted to be involved in adaptive immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 1/OR15-1 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 1/OR15-9 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy constant gamma P (non-functional)

SUMO1 pseudogene 3 (functional)

phosphatase and tensin homolog pseudogene 1 (functional)

PTENP1 represents a highly homologous processed pseudogene of PTEN (phosphatase and tensin homolog), a protein that encodes a tumor suppressor that functions by negatively regulating the AKT/PKB signaling pathway. PTENP1 is found on chromosome 9 and regulates PTEN by both sense and antisense RNAs (Gene ID: 101243555). This long-noncoding RNA (lncRNA) acts as a decoy for PTEN targeting microRNAs and also exerts a tumor suppressive activity. [provided by RefSeq, Jun 2020]

1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like

Predicted to enable transaminase activity. Predicted to be involved in amino acid metabolic process. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 19 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

immunoglobulin lambda variable 1-50 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta joining 2-2P (non-functional)

myosin light chain kinase pseudogene 1 (functional)

immunoglobulin heavy diversity 1-14 (non-functional)

immunoglobulin heavy diversity 4-11 (non-functional)

immunoglobulin heavy diversity 2/OR15-2B (non-functional)

immunoglobulin heavy diversity 2/OR15-2A (non-functional)

immunoglobulin kappa variable 6D-41 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 4/OR15-8 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin lambda variable 3-32 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 17 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 3-16 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

vimentin 2, pseudogene (functional)

immunoglobulin heavy diversity 4/OR15-4B (non-functional)

immunoglobulin heavy variable 3/OR16-12 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 3/OR16-10 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 35 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

olfactory receptor, family 10, subfamily D, member 3 (non-functional)

Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. [provided by RefSeq, Jul 2008]

immunoglobulin lambda variable 2-33 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 20/OR9-2 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy diversity 4/OR15-4A (non-functional)

immunoglobulin kappa variable 1/OR2-0 (non-functional)

immunoglobulin heavy variable 3/OR16-9 (non-functional)

Predicted to be involved in adaptive immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 3/OR16-8 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 1/OR15-5 (non-functional)

immunoglobulin kappa variable 6D-21 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

high mobility group AT-hook 1 pseudogene 8 (functional)

T cell receptor gamma variable 1 (non-functional)

Predicted to be involved in adaptive immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin kappa variable 1D-37 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 58 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

immunoglobulin kappa variable 1/OR2-108 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)

Enables identical protein binding activity. Predicted to be involved in amino acid metabolic process. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 61 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

T cell receptor alpha variable 8-7 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

T cell receptor beta variable 5-7 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 5-3 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin kappa variable 6-21 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 2/OR16-5 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy diversity 4-23 (non-functional)

immunoglobulin heavy variable 7-81 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy diversity 5/OR15-5B (non-functional)

immunoglobulin heavy diversity 5/OR15-5A (non-functional)

immunoglobulin heavy diversity 1/OR15-1B (non-functional)

immunoglobulin heavy diversity 1/OR15-1A (non-functional)

metallothionein 1D, pseudogene (functional)

Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including cellular response to zinc ion; detoxification of copper ion; and intracellular zinc ion homeostasis. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin heavy variable 1/OR21-1 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

fer-1-like family member 4, pseudogene (functional)

Predicted to enable metal ion binding activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Mar 2025]

solute carrier organic anion transporter family, member 1B7 (non-functional)

Predicted to enable bile acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Predicted to be involved in bile acid and bile salt transport and sodium-independent organic anion transport. Predicted to be located in plasma membrane. Predicted to be active in basolateral plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin kappa variable 1-37 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor beta variable 23-1 (non-functional)

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be located in immunological synapse. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Mar 2025]

T cell receptor alpha joining 59 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

immunoglobulin heavy variable 3-38-3 (non-functional)

Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin lambda variable 11-55 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

immunoglobulin lambda joining 5 (non-functional)

immunoglobulin lambda joining 4 (non-functional)

immunoglobulin kappa variable 3/OR2-268 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

dipeptidyl-peptidase 10 (non-functional)

This gene encodes a single-pass type II membrane protein that is a member of the S9B family in clan SC of the serine proteases. This protein has no detectable protease activity, most likely due to the absence of the conserved serine residue normally present in the catalytic domain of serine proteases. However, it does bind specific voltage-gated potassium channels and alters their expression and biophysical properties. Mutations in this gene have been associated with asthma. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)-like pseudogene

immunoglobulin heavy diversity 5-24 (non-functional)

T cell receptor beta variable 29/OR9-2 (non-functional)

Kirsten rat sarcoma viral oncogene homolog pseudogene 1 (functional)

T cell receptor gamma variable 11 (non-functional)

Predicted to be involved in adaptive immune response. Predicted to be located in external side of plasma membrane. Predicted to be part of T cell receptor complex. [provided by Alliance of Genome Resources, Mar 2025]

flavin containing monooxygenase 2 (non-functional)

This gene encodes a flavin-containing monooxygenase family member. It is an NADPH-dependent enzyme that catalyzes the N-oxidation of some primary alkylamines through an N-hydroxylamine intermediate. However, some human populations contain an allele (FMO2*2A) with a premature stop codon, resulting in a protein that is C-terminally-truncated, has no catalytic activity, and is likely degraded rapidly. This gene is found in a cluster with other related family members on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]

zinc finger protein 300 pseudogene 1 (functional)

T cell receptor alpha joining 1 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

T cell receptor alpha joining 2 (non-functional)

T cell receptors recognize foreign antigens which have been processed as small peptides and bound to major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells (APC). Each T cell receptor is a dimer consisting of one alpha and one beta chain or one delta and one gamma chain. In a single cell, the T cell receptor loci are rearranged and expressed in the order delta, gamma, beta, and alpha. If both delta and gamma rearrangements produce functional chains, the cell expresses delta and gamma. If not, the cell proceeds to rearrange the beta and alpha loci. This region represents the germline organization of the T cell receptor alpha and delta loci. Both the alpha and delta loci include V (variable), J (joining), and C (constant) segments and the delta locus also includes diversity (D) segments. The delta locus is situated within the alpha locus, between the alpha V and J segments. During T cell development, the delta chain is synthesized by a recombination event at the DNA level joining a D segment with a J segment; a V segment is then joined to the D-J gene. The alpha chain is synthesized by recombination joining a single V segment with a J segment. For both chains, the C segment is later joined by splicing at the RNA level. Recombination of many different V segments with several J segments provides a wide range of antigen recognition. Additional diversity is attained by junctional diversity, resulting from the random additional of nucleotides by terminal deoxynucleotidyltransferase. Five variable segments can be used in either alpha or delta chains and are described by TRAV/DV symbols. Several V and J segments of the alpha locus are known to be incapable of encoding a protein and are considered pseudogenes. [provided by RefSeq, Aug 2016]

immunoglobulin kappa variable 1D-42 (non-functional)

Predicted to be involved in immune response. Predicted to be located in extracellular region and plasma membrane. Predicted to be part of immunoglobulin complex. [provided by Alliance of Genome Resources, Mar 2025]

From HPO Gene-Disease Associations

genes associated with the functional abnormality of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Abnormality Of The Bladder in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From GWASdb SNP-Phenotype Associations

genes associated with the functional abnormality of the gastrointestinal tract phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.

From GWASdb SNP-Phenotype Associations

genes associated with the functional respiratory abnormality phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.

From GWASdb SNP-Phenotype Associations

genes associated with the functional abnormality of male internal genitalia phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional abnormality of male internal genitalia phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional respiratory abnormality phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional abnormality of the inner ear phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional abnormality of the middle ear phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional abnormality of the gastrointestinal tract phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Abnormality Of Male Internal Genitalia in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Abnormality Of The Gastrointestinal Tract in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; breast neoplasms; mammary neoplasms; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; neoplasms, prostatic; prostatic neoplasms; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; carcinoma, transitional cell; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; esophageal neoplasms; leiomyoma; lung neoplasms; neoplasm of lung ; oesophageal neoplasm; urinary bladder neoplasms; uterine neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease arsenic poisoning; bladder neoplasm; carcinoma, transitional cell; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder neoplasm; kidney neoplasms; ureteral neoplasms; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From Tabula Sapiens Gene-Cell Associations

genes with high or low expression in Bladder-bladder urothelial cell relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.

From Biocarta Pathways

proteins participating in the ion channels and their functional role in vascular endothelium pathway from the Biocarta Pathways dataset.

From dbGAP Gene-Trait Associations

genes associated with the trait Functional Laterality in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease functional diarrhea in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease functional gastric disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease functional colonic disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From GAD Gene-Disease Associations

genes associated with the disease functional laterality in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease unexplained (functional) dyspepsia. in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease functional differences in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GWAS Catalog SNP-Phenotype Associations

genes associated with the Functional impairment in major depressive disorder, bipolar disorder and schizophrenia phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.

From GWAS Catalog SNP-Phenotype Associations

genes associated with the Functional MRI phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.

From HPO Gene-Disease Associations

genes associated with the functional motor problems phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Hearing Loss, Functional phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Colonic Diseases, Functional phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Functional Laterality phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Triple functional domain protein protein domain from the InterPro Predicted Protein Domain Annotations dataset.

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Catalase, mono-functional, haem-containing protein domain from the InterPro Predicted Protein Domain Annotations dataset.

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Catalase, mono-functional, haem-containing, clades 1 and 3 protein domain from the InterPro Predicted Protein Domain Annotations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal functional residual capacity phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From Tabula Sapiens Gene-Cell Associations

genes with high or low expression in Eye-lacrimal gland functional unit cell relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Diarrhoea (Due To Spastic Colon) in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Gastrointestinal Disorders in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Diarrhea in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Constipation - Functional in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Proteinuria in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Colonic Diseases, Functional in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Neurological Symptom Disorder in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Mitral Regurgitation in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Disease Associations

genes associated with the disease Functional Disorder Of Intestine in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Abdominal Pain in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Intestinal Obstruction in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Motor Deficit in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Hyposplenism in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Abdominal Pain Syndrome in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Functional Laterality in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From MGI Mouse Phenotype Associations 2023

gene mutations causing the abnormal functional residual capacity phenotype in transgenic mice from the MGI Mouse Phenotype Associations 2023 dataset.

From CellMarker Gene-Cell Type Associations

genes associated with the Functional myeloid cell_Brain_Mouse cell type from the CellMarker Gene-Cell Type Associations dataset.

From WikiPathways Pathways 2024

proteins participating in the EV release from cardiac cells and their functional effects pathway from the WikiPathways Pathways 2024 dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores 2025

genes co-occuring with the disease Functional gastric disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores 2025

genes co-occuring with the disease Functional diarrhea in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores 2025

genes co-occuring with the disease Functional colonic disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.

From ClinVar Gene-Phenotype Associations 2025

genes associated with the Functional motor deficit phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Rapid functional decline in sporadic amyotrophic lateral sclerosis phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Gut microbiota (functional units) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the 3-month functional outcome in ischaemic stroke (modified Rankin score) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the 3-month functional outcome in non-lacunar ischaemic stroke (modified Rankin score) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the 3-month functional outcome in lacunar ischaemic stroke (modified Rankin score) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Meningococcal C functional antibody titers post childhood immunization phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Functional impairment in major depressive disorder, bipolar disorder and schizophrenia phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Functional MRI phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From GWAS Catalog SNP-Phenotype Associations 2025

genes associated with the Language functional connectivity phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.

From HPO Gene-Disease Associations

genes associated with the abnormality of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Abnormality Of The Bladder in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From DisGeNET Gene-Phenotype Associations

genes associated with the phenotype Abnormality Of Bladder Morphology in GWAS and other genetic association datasets from the DisGeNET Gene-Phenotype Associations dataset.

From BioGPS Mouse Cell Type and Tissue Gene Expression Profiles

genes with high or low expression in bladder relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder, Overactive from the curated CTD Gene-Disease Associations dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder Calculi from the curated CTD Gene-Disease Associations dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder, Neurogenic from the curated CTD Gene-Disease Associations dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder Neoplasms from the curated CTD Gene-Disease Associations dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder Diseases from the curated CTD Gene-Disease Associations dataset.

From CTD Gene-Disease Associations

genes/proteins associated with the disease Urinary Bladder Neck Obstruction from the curated CTD Gene-Disease Associations dataset.

From dbGAP Gene-Trait Associations

genes associated with the trait Urinary Bladder Neoplasms in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.

From DISEASES Curated Gene-Disease Association Evidence Scores

genes involed in the disease urinary bladder cancer from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Experimental Gene-Disease Association Evidence Scores

genes associated with the disease urinary bladder cancer in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder urothelial papillary carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder adenocarcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease invasive bladder transitional cell carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder diverticulum in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease non-invasive bladder papillary urothelial neoplasm in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder leiomyoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease nephrogenic adenoma of urinary bladder in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder calculus in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder benign neoplasm in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease neurogenic bladder in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease superficial urinary bladder cancer in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder carcinoma in situ in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder squamous cell carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder transitional cell papilloma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease urinary bladder cancer in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder sarcoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder neck obstruction in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder lymphoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease low compliance bladder in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder transitional cell carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder tuberculosis in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease bladder papillary transitional cell neoplasm in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From DISEASES Text-mining Gene-Disease Association Evidence Scores

genes co-occuring with the disease urinary bladder small cell neuroendocrine carcinoma in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

From GAD Gene-Disease Associations

genes associated with the disease leukemia; lung cancer; oropharyngolaryngeal cancers; laryngeal cancer; bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder cancer; cytogenetic studies in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease urinary bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease leukemia; bladder cancer; radiotherapy in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease cigarette smoking- related bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease transitional cell carcinoma of the bladder. in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease lung cancer; breast cancer; bladder cancer; cervical cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease lung cancer; esophageal cancer; stomach cancer; bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease kidney cancer; bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease carcinoma, transitional cell; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease neoplasm recurrence, local; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease colorectal cancer; drug hypersensitivity; liver cancer; bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease carcinoma; neoplasm invasiveness; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease superficial bladder tumors in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease lung cancer; esophageal cancer; stomach cancer; bladder cancer; warfarin sensitivity in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease lung cancer; bladder cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder cancer; prostate cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder cancer. in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease carcinoma, transitional cell; kidney neoplasms; neoplasm invasiveness; ureteral neoplasms; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease bladder cancer, urinary in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease carcinoma, transitional cell; tobacco use disorder; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease leukemia; lung cancer; laryngeal cancer; bladder cancer; oral-pharyngeal cancer in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GAD Gene-Disease Associations

genes associated with the disease carcinoma; urinary bladder neoplasms in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.

From GeneRIF Biological Term Annotations

genes co-occuring with the biological term bladder in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.

From GEO Signatures of Differentially Expressed Genes for Gene Perturbations

genes differentially expressed following the ARHGDIB_Transfection_GDS4455_551_human_UM-UC-3 bladder carcinoma cells gene perturbation from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.

From GO Biological Process Annotations 2015

genes participating in the urinary bladder smooth muscle contraction biological process from the curated GO Biological Process Annotations 2015 dataset.

From GO Biological Process Annotations 2015

genes participating in the gall bladder development biological process from the curated GO Biological Process Annotations 2015 dataset.

From GO Biological Process Annotations 2015

genes participating in the urinary bladder development biological process from the curated GO Biological Process Annotations 2015 dataset.

From GTEx Tissue Gene Expression Profiles

genes with high or low expression in bladder relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.

From GWAS Catalog SNP-Phenotype Associations

genes associated with the Bladder cancer phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.

From GWAS Catalog SNP-Phenotype Associations

genes associated with the Bladder cancer (smoking interaction) phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.

From GWAS Catalog SNP-Phenotype Associations

genes associated with the Urinary bladder cancer phenotype in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.

From GWASdb SNP-Disease Associations

genes associated with the disease bladder carcinoma in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.

From GWASdb SNP-Disease Associations

genes associated with the disease urinary bladder cancer in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.

From GWASdb SNP-Phenotype Associations

genes associated with the bladder neoplasm phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.

From GWASdb SNP-Phenotype Associations

genes associated with the bladder carcinoma phenotype in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.

From HPA Tissue Gene Expression Profiles

genes with high or low expression in urinary bladder relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.

From HPA Tissue Protein Expression Profiles

proteins with high or low expression in urinary bladder relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.

From HPO Gene-Disease Associations

genes associated with the bladder exstrophy phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the autonomic bladder dysfunction phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the transitional cell carcinoma of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the bladder fistula phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the dilatation of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the hypoplasia of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the bladder neoplasm phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the aplasia/hypoplasia of the bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the bladder carcinoma phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the bladder diverticulum phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the urinary bladder sphincter dysfunction phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the urinary bladder inflammation phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HPO Gene-Disease Associations

genes associated with the neurogenic bladder phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Urinary Bladder, Overactive phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Urinary Bladder Neoplasms phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From HuGE Navigator Gene-Phenotype Associations

genes associated with the Bladder Exstrophy phenotype by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Bladder cancer-related BC10-like protein domain from the InterPro Predicted Protein Domain Annotations dataset.

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Bladder cancer-related BC10 protein domain from the InterPro Predicted Protein Domain Annotations dataset.

From KEGG Pathways

proteins participating in the bladder cancer pathway from the KEGG Pathways dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder weight phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder obstruction phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the absent urinary bladder phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder detrusor smooth muscle morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the increased urinary bladder transitional cell carcinoma incidence phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the impaired contractility of urinary bladder detrusor smooth muscle phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder cysts phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder mucosa morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the orotic acid urinary bladder stones phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal bladder urine volume phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the distended urinary bladder phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder exstrophy phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder fibrosis phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder physiology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the thin urinary bladder urothelium phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder blood vessel morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the increased urinary bladder carcinoma incidence phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the increased urinary bladder weight phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder inflammation phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the absent urinary bladder urothelium phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the urinary bladder hypoplasia phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the neurogenic bladder phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder neck morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From MPO Gene-Phenotype Associations

gene mutations causing the abnormal urinary bladder urothelium morphology phenotype in transgenic mice from the MPO Gene-Phenotype Associations dataset.

From OMIM Gene-Disease Associations

genes associated with the {bladder cancer, somatic} phenotype from the curated OMIM Gene-Disease Associations dataset.

From OMIM Gene-Disease Associations

genes associated with the {?bladder cancer susceptibility} phenotype from the curated OMIM Gene-Disease Associations dataset.

From OMIM Gene-Disease Associations

genes associated with the bladder cancer, somatic phenotype from the curated OMIM Gene-Disease Associations dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-S5-AA26-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HG-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47T-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BR-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-2F-A9KR-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-LT-A8JT-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9R4-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BU-01A-31R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A42C-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BL-A0C8-01A-11R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A2I4-01A-11R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-C4-A0F0-01A-12R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-HQ-A5NE-01A-12R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-LT-A5Z6-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-C4-A0EZ-01A-21R-A24X-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BL-A5ZZ-01A-31R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3NA-01A-11R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A6AV-01A-12R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A0YX-01A-11R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A5U8-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-HQ-A2OE-01A-11R-A206-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A27C-01A-11R-A16R-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A78K-01A-11R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A78O-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SR-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A43Y-01A-21R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B8-01A-31R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3X2-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20W-01A-21R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TG-01A-11R-A32O-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A62O-01A-11R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A6MD-01A-41R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HD-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BS-01A-21R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A9PD-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A72E-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A5RI-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3IM-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A5KE-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47X-01A-31R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FJ-A3ZE-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-2F-A9KQ-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B6-01A-21R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A2C5-01A-12R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A2LD-01A-12R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20W-11A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HC-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BX-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A85H-01A-11R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A3MH-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A5RI-11A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GU-A42R-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SN-01A-12R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A9PB-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A1AD-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A7XN-01A-11R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-2F-A9KT-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3I6-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A8HY-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-2F-A9KO-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9RE-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-YC-A89H-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FJ-A3Z9-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HF-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A1HS-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-C4-A0F6-01A-11R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A2EC-01A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GU-A764-01A-11R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20N-01A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A62N-01A-11R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A3OP-11A-11R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A5UA-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9RF-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3RB-01A-12R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A3YL-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SS-01A-12R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HB-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B4-01A-12R-A206-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A2LA-01A-11R-A18C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3RD-01A-12R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A6B5-01A-11R-A31N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3WC-11A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-MV-A51V-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-AAQO-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3WY-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A2ES-01A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-AA4U-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-PQ-A6FN-01A-11R-A31N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20N-11A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47Y-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A5KF-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3BM-11A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3QH-01A-11R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A78M-01A-21R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A40G-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3JW-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A43X-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A3X6-01A-12R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A3IE-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-SY-A9G0-01A-12R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A3VY-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A6B1-01A-12R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A83P-01A-11R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A2EJ-01A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A6MF-01A-12R-A32O-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A9FM-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A2EK-01A-22R-A18C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3QF-01A-31R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TK-01A-42R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TD-01A-51R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A3MG-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BL-A3JM-01A-12R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TF-01A-52R-A32O-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A2EL-01A-12R-A18C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9RC-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-AA4N-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A6ZA-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B3-01A-12R-A206-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3QK-01B-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20R-01A-12R-A16R-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B7-01A-31R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HE-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FJ-A871-01A-11R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A9PE-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A1A6-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A7DV-01A-11R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3RC-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A62P-01A-32R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A8O8-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20P-01A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SQ-01A-21R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A3WU-01B-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A42F-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A76B-01A-11R-A32O-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A9FL-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A2C5-11A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20R-11A-11R-A16R-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A4AC-01A-21R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A541-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A1AE-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-XF-A8HH-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A5RH-01A-11R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-KQ-A41O-01A-12R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FJ-A3ZF-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9RM-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3WX-01A-22R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-AA4V-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3QG-01A-11R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3WC-01A-31R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-H4-A2HO-01A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A3YS-01A-11R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3N6-01A-11R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BZ-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E5-A2PC-01A-11R-A206-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SL-01A-21R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3SM-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A678-01A-11R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TC-01A-21R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-AA4W-01A-12R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TB-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A1HR-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A6AW-01A-11R-A30C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A4AB-01B-12R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3JZ-01A-11R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3X1-01A-12R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GU-A42Q-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3IQ-01A-31R-A32Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A5BY-01A-31R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47V-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A4ZW-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A43U-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3IK-01A-32R-A21D-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A3JV-01A-11R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A0YN-01A-21R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47S-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TI-01A-11R-A32O-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A7I0-01A-22R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A3OP-01A-21R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A3WV-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A3B5-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20T-01A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A4IJ-01A-31R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A5W6-01A-11R-A28M-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A3QU-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20Q-01A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A3WV-11A-21R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TE-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-KQ-A41N-01A-11R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A42E-01A-11R-A23W-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A3IU-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-E7-A3Y1-01A-11R-A22U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20V-01A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A2I1-01A-11R-A180-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-KQ-A41P-01A-12R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9R9-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A3IB-01A-11R-A20F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A3PK-01A-21R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A8OC-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-KQ-A41Q-01A-11R-A33J-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A2HX-01A-12R-A18C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A1AB-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-K4-A54R-01A-11R-A26T-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GD-A3OQ-11A-21R-A220-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BL-A13J-11A-13R-A10U-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-KQ-A41R-01A-21R-A352-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A8HX-01A-11R-A36F-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A1AC-01A-11R-A13Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GV-A40E-01A-12R-A23N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20U-11A-11R-A14Y-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-AA4R-01A-11R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-GC-A6I3-11A-11R-A31N-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A2LA-11A-11R-A18C-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.

From TCGA Signatures of Differentially Expressed Genes for Tumors

genes with high or low expression in Bladder Urothelial Carcinoma_BLCA_TCGA-YC-A8S6-01A-31R-A38B-07 relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.